blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1513552

EP1513552 - PACKAGED VIRUS-LIKE PARTICLES IN COMBINATION WITH CPG FOR USE AS ADJUVANTS WITH ALLERGENS : METHOD OF PREPARATION AND USE [Right-click to bookmark this link]
Former [2005/11]PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE
[2009/49]
StatusNo opposition filed within time limit
Status updated on  07.10.2011
Database last updated on 24.03.2026
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Cytos Biotechnology AG
Wagistrasse 25
8952 Schlieren / CH
[2005/11]
Inventor(s)01 / BACHMANN, Martin, F.
Goldackerweg 8
CH-8472 Seuzach / CH
02 / RENNER, Wolfgang, A.
Grenzsteig 9
CH-8802 Kilchberg / CH
 [2005/11]
Representative(s)Wichmann, Hendrik, et al
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstraße 2
81541 München / DE
[N/P]
Former [2010/43]Wichmann, Hendrik, et al
Wuesthoff & Wuesthoff Schweigerstrasse 2
81541 München / DE
Former [2005/11]Wichmann, Hendrik, Dr.
Isenbruck Bösl Hörschler Wichmann Huhn, Prinzregentenstrasse 68
81675 München / DE
Application number, filing date03760672.020.06.2003
[2005/11]
WO2003EP06541
Priority number, dateUS20020389898P20.06.2002         Original published format: US 389898 P
[2005/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004000351
Date:31.12.2003
Language:EN
[2004/01]
Type: A1 Application with search report 
No.:EP1513552
Date:16.03.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 31.12.2003 takes the place of the publication of the European patent application.
[2005/11]
Type: B1 Patent specification 
No.:EP1513552
Date:01.12.2010
Language:EN
[2010/48]
Search report(s)International search report - published on:EP31.12.2003
ClassificationIPC:A61K39/39, A61P37/04
[2005/11]
CPC:
C12N7/00 (EP,US); A61K39/0011 (EP,US); A61K39/001104 (EP,US);
A61K39/001106 (EP,US); A61K39/001129 (EP,US); A61K39/001151 (EP,US);
A61K39/001156 (EP,US); A61K39/001171 (EP,US); A61K39/001182 (EP,US);
A61K39/001186 (EP,US); A61K39/001191 (EP,US); A61K39/001192 (EP,US);
A61K39/35 (EP,US); A61K39/385 (EP,US); A61K39/39 (EP,US);
A61P31/12 (EP); A61P35/00 (EP); A61P37/04 (EP);
A61P37/08 (EP); C07K14/005 (EP,US); A61K2039/5258 (EP,US);
A61K2039/55516 (EP,US); A61K2039/55561 (EP,US); A61K2039/55588 (EP,US);
A61K2039/57 (EP,US); A61K2039/6075 (EP,US); C12N2730/10122 (EP,US);
C12N2730/10123 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/11]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:VERPACKTE VIRUSARTIGE PARTIKEL IN KOMBINATION MIT CPG ZUR VERWENDUNG ALS ADJUVANTIEN MIT ALLERGENEN. HERSTELLUNGSVERFAHREN UND VERWENDUNG[2009/49]
English:PACKAGED VIRUS-LIKE PARTICLES IN COMBINATION WITH CPG FOR USE AS ADJUVANTS WITH ALLERGENS : METHOD OF PREPARATION AND USE[2009/49]
French:PARTICULES PSEUDO-VIRALES ENVELOPPEES COMBINEES AU CPG DESTINEES A ETRE UTILISEES EN TANT QU'ADJUVANTS AVEC DES ALLERGENES: PROCEDE DE PREPARATION ET UTILISATION DE CELLES-CI[2009/49]
Former [2005/11]VERPACKTE VIRUSARTIGE PARTIKEL ZUR VERWENDUNG ALS ADJUVANTIEN. HERSTELLUNGSVERFAHREN UND VERWENDUNG
Former [2005/11]PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE
Former [2005/11]PARTICULES PSEUDO-VIRALES ENVELOPPEES DESTINEES A ETRE UTILISEES EN TANT QU'ADJUVANTS: PROCEDE DE PREPARATION ET UTILISATION DE CELLES-CI
Entry into regional phase23.11.2004National basic fee paid 
23.11.2004Designation fee(s) paid 
23.11.2004Examination fee paid 
Examination procedure20.01.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.11.2004Examination requested  [2005/11]
05.11.2007Despatch of a communication from the examining division (Time limit: M06)
27.08.2008Reply to a communication from the examining division
17.12.2009Communication of intention to grant the patent
07.06.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
03.08.2010Fee for grant paid
03.08.2010Fee for publishing/printing paid
Opposition(s)02.09.2011No opposition filed within time limit [2011/45]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
03.08.2010Request for further processing filed
03.08.2010Full payment received (date of receipt of payment)
Request granted
19.08.2010Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
27.08.2008Request for further processing filed
27.08.2008Full payment received (date of receipt of payment)
Request granted
22.09.2008Decision despatched
Fees paidRenewal fee
27.06.2005Renewal fee patent year 03
30.03.2006Renewal fee patent year 04
14.06.2007Renewal fee patent year 05
13.03.2008Renewal fee patent year 06
16.06.2009Renewal fee patent year 07
29.06.2010Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
DK01.12.2010
EE01.12.2010
FI01.12.2010
HU01.12.2010
IT01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
TR01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
IE20.06.2011
LU20.06.2011
MC30.06.2011
[2013/45]
Former [2013/44]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
DK01.12.2010
EE01.12.2010
FI01.12.2010
IT01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
TR01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
IE20.06.2011
LU20.06.2011
MC30.06.2011
Former [2013/25]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
DK01.12.2010
EE01.12.2010
FI01.12.2010
IT01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
IE20.06.2011
LU20.06.2011
MC30.06.2011
Former [2013/21]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
DK01.12.2010
EE01.12.2010
FI01.12.2010
IT01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
IE20.06.2011
MC30.06.2011
Former [2012/20]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
DK01.12.2010
EE01.12.2010
FI01.12.2010
IT01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
IE20.06.2011
Former [2012/03]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
DK01.12.2010
EE01.12.2010
FI01.12.2010
IT01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
Former [2011/47]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
DK01.12.2010
EE01.12.2010
FI01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
Former [2011/37]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
EE01.12.2010
FI01.12.2010
NL01.12.2010
RO01.12.2010
SE01.12.2010
SI01.12.2010
SK01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
Former [2011/35]AT01.12.2010
BE01.12.2010
CY01.12.2010
CZ01.12.2010
EE01.12.2010
FI01.12.2010
NL01.12.2010
SE01.12.2010
SI01.12.2010
BG01.03.2011
GR02.03.2011
ES12.03.2011
PT01.04.2011
Former [2011/31]AT01.12.2010
CY01.12.2010
FI01.12.2010
NL01.12.2010
SE01.12.2010
SI01.12.2010
BG01.03.2011
GR02.03.2011
Former [2011/24]CY01.12.2010
FI01.12.2010
NL01.12.2010
SE01.12.2010
Cited inInternational search[A]   GERBER S ET AL: "Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 75, no. 10, May 2001 (2001-05-01), pages 4752 - 4760, XP002246338, ISSN: 0022-538X [A] 1-121 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.75.10.4752-4760.2001
by applicant  PIRCHER ET AL.: "Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen", NATURE, vol. 342, 1989, pages 559
   TISSOT ET AL.: "Characterizing the functionality of recombinant T-cell receptors in vitro: a pMHC tetramer based approach", J IMMUNOL METHODS, vol. 236, 2000, pages 147, XP004190754, DOI: doi:10.1016/S0022-1759(99)00226-4

DOI:   http://dx.doi.org/10.1016/S0022-1759(99)00226-4
   BACHMANN ET AL.: "Four types of Ca2+-signals after stimulation of naive T cells with T cell agonists, partial agonists and antagonists", EUR. J. IMMUNOL., vol. 27, 1997, pages 3414
   BACHMANN ET AL.: "Functional maturation of an anti-viral cytotoxic T cell response", J. VIROL., vol. 71, 1997, pages 5764 [A] 1-121 * the whole document *
   BACHMANN ET AL.: "Peptide induced TCR-down regulation on naive T cell predicts agonist/partial agonist properties and strictly correlates with T cell activation", EUR. J. IMMUNOL., vol. 27, 1997, pages 2195
   BACHMANN ET AL.: "Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation", IMMUNITY, vol. 7, 1997, pages 549
   OHASHI ET AL.: "Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice", CELL, vol. 65, 1991, pages 305
   KIINDIG ET AL.: "Fibroblasts act as efficient antigen-presenting cells in lymphoid organs", SCIENCE, vol. 268, 1995, pages 1343
   SPEISER ET AL.: "CTL tumor therapy specific for an endogenous antigen does not cause autoimmune disease", J. EXP. MED., vol. 186, 1997, pages 645
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.